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The Life Cycle Stages of Pneumocystis murina Have Opposing Effects
on the Immune Response to This Opportunistic Fungal Pathogen
Heather M. Evans,a Grady L. Bryant III,a Beth A. Garvya,b
Department of Microbiology, Immunology, and Molecular Geneticsa and Division of Infectious Diseases, Department of Internal Medicine,b University of Kentucky College
of Medicine, Lexington, Kentucky, USA
The cell wall-glucans of Pneumocystis cysts have been shown to stimulate immune responses in lung epithelial cells, dendritic
cells, and alveolar macrophages. Little is known about how the trophic life forms, which do not have a fungal cell wall, interact
with these innate immune cells. Here we report differences in the responses of both neonatal and adult mice to the trophic and
cystic life cycle stages of Pneumocystis murina. The adult and neonatal immune responses to infection with Pneumocystis
murina trophic forms were less robust than the responses to infection with a physiologically normal mixture of cysts and trophic
forms. Cysts promoted the recruitment of nonresident innate immune cells and T and B cells into the lungs. Cysts, but not
trophic forms, stimulated increased concentrations of the cytokine gamma interferon (IFN-) in the alveolar spaces and an in-
crease in the percentage of CD4 T cells that produce IFN-. In vitro, bone marrow-derived dendritic cells (BMDCs) stimulated
with cysts produced the proinflammatory cytokines interleukin 1 (IL-1) and IL-6. In contrast, trophic forms suppressed anti-
gen presentation to CD4 T cells, as well as the-glucan-, lipoteichoic acid (LTA)-, and lipopolysaccharide (LPS)-induced pro-
duction of interleukin 1 (IL-1), IL-6, and tumor necrosis factor alpha (TNF-) by BMDCs. The negative effects of trophic
forms were not due to ligation of mannose receptor. Our results indicate that optimal innate and adaptive immune responses to
Pneumocystis species are dependent on stimulation with the cyst life cycle stage. Conversely, trophic forms suppress -glucan-
induced proinflammatory responses in vitro, suggesting that the trophic forms dampen cyst-induced inflammation in vivo.
Pneumocystis species are opportunistic fungal pathogens thatcause severe pneumonia in immunocompromised hosts, in-
cluding AIDS patients. Clearance of Pneumocystis organisms is
dependent on effective CD4 T and B cell and macrophage re-
sponses (1–4). Failure to clear Pneumocystis organisms leads to
severe alveolar damage due to the exaggerated inflammatory im-
mune response (5). In spite of a reduced incidence ofPneumocystis
pneumonia (PcP) in HIV-infected individuals due to improved
antiviral therapies, the mortality rate for patients with PcP has not
improved with the implementation of highly active antiretroviral
therapy (HAART) (6). Additional studies are required to inform
novel approaches to reduce morbidity and mortality due to Pneu-
mocystis pneumonia.
Outbreaks of PcP were first described in malnourished or pre-
mature infants in orphanages following the Second World War
(7). Evidence suggests that immunocompetent individuals of all
ages are capable of mounting protective immune responses to
Pneumocystis jirovecii that prevent progression to pneumonia.
Most children encounter this opportunistic fungus at a young age,
as indicated by the presence of specific antibodies in the sera of
85% of individuals by the age of 3 years (8). Previous work from
our lab has shown that the neonatal mouse immune response to
Pneumocystis is delayed, due in part to an anti-inflammatory lung
environment (9–12). The neonatal lung environment is charac-
terized by anti-inflammatory mediators, including transforming
growth factor 1 (TGF-1) and interleukin 10 (IL-10), and im-
mature immune cells (9–12). Neonatal alveolar macrophages and
T cells adoptively transferred to an adult lung environment are
competent at resolving Pneumocystis murina pneumonia in mice
(9, 12). In addition, neonatal alveolar macrophages are deficient
in NF-B translocation following stimulation with Pneumocystis
organisms (9). Neonatal alveolar CD11c cells demonstrate de-
layed trafficking to the draining lymph nodes (11). Together, these
data indicate that both the neonatal lung environment and intrin-
sic immune cell deficits contribute to the delayed clearance of P.
murina in neonatal mice.
Pneumocystis species have a biphasic life cycle. Trophic forms
are proposed to represent the asexual stage of the life cycle,
whereas cysts are the ascus-like sexual stage (13). Trophic forms
are single-nucleated organisms that are typically found in clusters
surrounded by a biofilm-like substance consisting of a conglom-
eration of DNA, -glucan, and other sugars (14). Cysts are ascus-
like structures that consist of multiple nuclei surrounded by a
fungal cell wall.-1,3-Glucan and-1,6-glucan serve as the struc-
tural components of the cyst wall (15, 16). Trophic forms do not
express -glucan (15). Both stages express surface glycoproteins
and mannoproteins, which may serve as pathogen-associated mo-
lecular patterns (PAMPs) that could interact with receptors on
phagocytic cells (17–19). Neither life form expresses chitin or
-glucans (20).
Dendritic cells are the principal antigen-presenting cells in the
lung. However, their role in initiating the adaptive response to
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Pneumocystis organisms has been understudied. Previous work
has demonstrated that dendritic cells respond to -glucans de-
rived from thePneumocystis cell wall (21). Dendritic cells activated
by Pneumocystis cell wall-derived -glucans increase costimula-
tory molecule expression and drive T cell polarization toward a
Th1-type response (21). The mechanism for dendritic cell recog-
nition of Pneumocystis trophic forms, which do not express-glu-
cans, is unknown.
Improved understanding of innate immune interactions with
the cystic and trophic life cycle stages has the potential to inform
future treatment of Pneumocystis pneumonia. Recently, it was re-
ported that treatment of mice with the -1,3-D-glucan synthase
inhibitor anidulafungin resulted in depletion of P. murina cysts
(22). The mice were able to control the remaining trophic burden
in the absence of an excessive inflammatory response; however,
the details of how trophic forms are recognized and cleared are not
known.
In this study, we demonstrate that both the adult and the neo-
natal immune responses to infection withP.murina trophic forms
alone were less robust than the responses to infection with a phys-
iologically normal mixture of cysts and trophic forms. Infection
with trophic forms alone resulted in less recruitment of activated
CD4 and CD8 T cells into the lungs of both neonatal and adult
mice than infection with a normal mixture of trophic forms and
cysts. Infection with a mixture of P. murina organisms drove the
recruitment of nonresident innate immune cells into the lung pa-
renchyma and alveolar spaces. In vitro, trophic forms suppressed
the production of the proinflammatory cytokines IL-1, IL-6, and
tumor necrosis factor alpha (TNF-) by bone marrow-derived
dendritic cells (BMDCs) stimulated with -glucan, lipoteichoic
acid (LTA), or lipopolysaccharides (LPS). In addition, trophic-
form-stimulated BMDCs failed to stimulate production of the
Th1-type cytokine gamma interferon (IFN-) by CD4
 T cells.
We report for the first time that the trophic forms of P. murina
suppress -glucan-induced proinflammatory responses.
MATERIALS AND METHODS
Mice. Six-week-old BALB/cJ, dectin-1 knockout (dectin-1 KO; B6.129S6-
Clec7atm1Gdb/J) and mannose receptor knockout (MR/; B6.129P2-
Mrc1tm1Mnz/J) mice were purchased from The Jackson Laboratory (Bar
Harbor, ME) and were bred in our animal facilities. Male and female pups
were used in the neonatal experiments. Six-week-old female BALB/cJ
mice were purchased from The Jackson Laboratory and were infected at
the age of 8 weeks either for the adult experiments or to generate CD4 T
cells for the in vitro experiments. Uninfected adult female BALB/cJ,
dectin-1 KO, MR/, and B6.129P2 mice from The Jackson Labora-
tory were used to generate BMDCs for the in vitro experiments. Mice
were maintained at the University of Kentucky Department of Labo-
ratory Animal Resources (DLAR) under specific-pathogen-free condi-
tions. C.129S6(B6)-Rag2tm1Fwa N12 (Rag2/) mice, originally from
Taconic (Germantown, NY), were used to maintain a source of P. murina
and were bred at the DLAR in sterile microisolator cages with sterilized
food and water. The University of Kentucky Institutional Animal Care
and Use Committee approved all protocols regarding animal use.
P. murina isolation and infection. Lungs were excised from P.
murina-infected Rag2/ mice and were pushed through stainless steel
mesh in Hanks’ balanced salt solution (HBSS) containing 0.5% glutathi-
one at pH 7.3. Cell debris was broken up by aspirating through 20- and
26-gauge needles and was then removed by centrifugation at 100 g for 3
min. Trophic forms were isolated by removing the supernatant following
centrifugation at 400  g for 7 min. This preparation results in 	99%
pure trophic forms (see Fig. S1 in the supplemental material). The pellet
from the 400 g spin contained a mixed population of cysts and trophic
forms, at a typical ratio of 10:1 (trophic forms to cysts). Erythrocytes in the
pellet were lysed with water, and organisms were suspended in an equal
volume of 2 phosphate-buffered saline (PBS). Organisms were incu-
bated with 200 U DNase (Sigma-Aldrich, St. Louis MO) at 37°C for 30
min. Clumps were broken up by aspirating through a 26-gauge needle.
The remaining cell debris was removed by centrifugation at 100 g for 3
min, followed by passage over a 70-
m filter. Aliquots of mixed P.murina
organisms or purified trophic forms were diluted, and 100-
l aliquots
were spun onto a 28.3-mm2 area of glass slides. Slides were fixed in meth-
anol and were stained with Diff-Quik (Siemens Healthcare Diagnostics,
Inc., Deerfield, IL). Organism numbers were determined microscopically
using the 100 oil immersion objective of a Nikon microscope.
Mice were anesthetized lightly with isoflurane anesthesia to suppress
the diver’s reflex. Neonatal mice (24 to 72 h old) were inoculated intrana-
sally (i.n.) with 106 trophic or mixed P. murina organisms in 10 
l HBSS
containing 10 U/ml penicillin, 10 
g/ml streptomycin, and 1 
g/ml gen-
tamicin. Adult mice (6 to 8 weeks old) were inoculated intratracheally
(i.t.) with 107 trophic or mixed P. murina organisms in 100 
l HBSS
containing antibiotics. The adult mice were placed on an upright support
rack, and the inoculations were performed using a blunted intratracheal
needle designed with a curve to accommodate the trachea.
Isolationof cells fromalveolar spaces, lungs, and lymphnodes.Mice
were exsanguinated under deep isoflurane anesthesia, and lungs were la-
vaged with 5 washes of HBSS containing 3 mM EDTA. Bronchial alveolar
lavage fluid (BALF) was centrifuged to obtain cells, and the cell-free su-
pernatant from the first wash was frozen for subsequent cytokine assays.
Right lung lobes were excised, minced, and digested in RPMI medium
containing 3% heat-inactivated fetal calf serum, 1 mg/ml collagenase A
(Sigma-Aldrich, St. Louis MO), and 50 U/ml DNase for 1 h at 37°C.
Digested lungs were pushed through 70-
m nylon mesh screens to obtain
single-cell suspensions, and aliquots were taken for enumeration of P.
murina. Tracheobronchial lymph nodes (TBLN) were also excised and
were pushed through 70-
m nylon mesh screens in HBSS. Erythrocytes
were removed using hypotonic ammonium-chloride-potassium (ACK)
lysing buffer. Cells were washed and were counted by hemocytometer.
Flow cytometric analysis. BALF, lung digest, and TBLN cells were
washed with PBS containing 0.1% bovine serum albumin and 0.02%
NaN3 and were stained with appropriate concentrations of fluoro-
chrome-conjugated antibodies specific for murine lymphocytes (anti-
CD4 clone GK1.5, anti-CD8a clone 53-6.7, anti-CD19 clone 1D3, anti-
CD44 clone IM7, and anti-CD62L clone MEL-14) or innate immune cells
(anti-CD11c clone N418, anti-CD11b clone M1/70). Antibodies were
purchased from BD Biosciences (San Jose, CA) or eBioscience (San Diego,
CA). Expression of these molecules on the surfaces of the cells was deter-
mined by multiparameter flow cytometry using an LSR II flow cytometer
(BD Biosciences). A total of 50,000 events were routinely acquired and
were analyzed using FlowJo software (TreeStar, USA).
Enumeration of Pneumocystis organisms in the lungs of mice. Ali-
quots of lung homogenates were spun onto glass slides and were stained as
described above. The number of P. murina trophic forms or cysts in 50
microscopic oil immersion fields was used to calculate fungal burden.
Lung burden is expressed as the number of P. murina organisms per right
lung lobe, and the limits of detection were log10 3.12 nuclei per neonatal
right lung lobe and log10 3.42 nuclei per adult right lung lobe.
Generation of BMDCs and CD4 T cells for in vitro assays. BMDCs
were generated from uninfected BALB/cJ, B6.129P2, dectin-1 KO, and
MR/ adult female mice. BMDCSs were produced by flushing cells from
the bone marrow of the tibias and femurs of female adult mice with PBS
plus 5% heat-inactivated fetal bovine serum (FBS; Atlas Biologicals, Fort
Collins, CO). Erythrocytes were removed using ACK lysing buffer (23).
Cells were washed and were resuspended in a culture medium containing
RPMI medium with 10% heat-inactivated FBS, 0.5 mM 2-mercaptoetha-
nol, 1% MEM nonessential amino acid solution (ATCC, Manassas, VA),
100 U/ml penicillin, 100 
g/ml streptomycin, and 50 
g/ml gentamicin
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(Thermo Fisher Scientific, Waltham, MA). Cells were plated in 100-mm
petri dishes at a density of 4 106 in 10 ml culture medium with 20 ng/ml
recombinant murine granulocyte-macrophage colony-stimulating factor
(GM-CSF; Peprotech, Rocky Hill, NJ). Plates were cultured at 37°C under
5.0% CO2. An additional 10 ml of culture medium with 20 ng/ml recom-
binant murine GM-CSF was added to cells after 24 h of growth. Every 48
h thereafter, nonadherent cells were removed and were replaced with 10
ml of fresh medium containing recombinant murine GM-CSF. Cells were
cultured for 9 to 12 days. BMDCs were collected by vigorously washing
plates with medium to remove loosely adherent cells. BMDCs were
washed, resuspended, and split for phenotyping or a cytokine assay. More
than 80% of recovered cells were CD11c. CD4 T cells were generated
by infecting adult BALB/cJ mice with 107 mixed P. murina organisms as
described above. TBLN were excised 10 to 14 days postinfection and were
pushed through 70-
m nylon mesh screens in HBSS. Erythrocytes were
removed using ACK lysing buffer. Cells were washed and counted. CD4
(L3T4) microbeads (Miltenyi Biotec, San Diego, CA) were used for posi-
tive selection of CD4 cells. More than 90% of recovered cells were CD4
T cells.
In vitro cytokine production assays. A total of 104 BMDCs and/or
5  104 CD4 T cells in 96-well plates were stimulated with 10 
g/ml
curdlan (-1,3-glucan from Alcaligenes faecalis; Sigma-Aldrich), 20

g/ml zymosan (Saccharomyces cerevisiae cell wall; Sigma-Aldrich), 20

g/ml depleted zymosan (InvivoGen, San Diego, CA), 10 
g/ml lipo-
teichoic acid (LTA) (from Bacillus subtilis; Sigma-Aldrich), 100 ng/ml
lipopolysaccharides (LPS) (from Escherichia coli 0111:B4; purified by gel
filtration to remove lipoproteins; Sigma-Aldrich), 5 105 trophic forms,
and/or 5 105 mixedP.murina organisms at 37°C under 5.0% CO2 for 72
h in BMDC culture medium. Supernatants were collected, centrifuged at
2,700  g for 1 min to remove organisms, and frozen for subsequent
analysis of cytokine levels using IL-1, IL-6, TNF-, and IFN- enzyme-
linked immunosorbent assay (ELISA) kits (eBioscience, San Diego CA).
Trypan blue (Sigma-Aldrich) was used to evaluate the viability of BMDCs
following stimulation with 10 
g/ml curdlan, 5  105 trophic forms,
and/or 5 105 mixedP.murina organisms at 37°C under 5.0% CO2 for 72
h in BMDC culture medium.
Statistical analysis. Data were analyzed utilizing the SigmaStat statis-
tical software package (SPSS Inc., Chicago, IL). Student’s t test with one-
way or two-way analysis of variance (ANOVA) was used to determine
differences between groups, with Student-Newman-Keuls or Holm-Sidak
multiple-comparison post hoc tests. Kruskal-Wallis one-way ANOVA on
ranks was used to analyze differences between groups when the data were
nonparametric. Data were determined to be significantly different when
the P value was0.05.
RESULTS
P. murina trophic forms encyst by day 14 postinfection in neo-
natal mice. Recent evidence indicates that cysts are the transmit-
table life cycle stage ofPneumocystis species (24). However, there is
a paucity of data regarding how the immune system handles the
trophic forms of the organisms. We previously published a report
that alveolar macrophages from either adult or neonatal mice
failed to translocate NF-B in response to trophic forms (9).
Therefore, we first wanted to know how the immune response
differed when cysts were absent early in the infection and how
quickly after infection trophic forms transitioned to cysts. To eval-
uate the differential immune response to the life cycle stages, we
infected wild-type neonatal mice with either pure trophic forms or
a physiologically normal mixture of P. murina trophic forms and
cysts (Fig. S1 in the supplemental material). Neonatal mice in-
fected with a normal mixture ofP.murinaorganisms fail to mount
adaptive immune responses until the age of 21 days (9). This pres-
ents an opportunity to observe the growth of the life cycle stages of
P. murina in the absence of protective responses.
Trophic forms were detected at day 5 postinfection in the lungs
of BALB/cJ neonates infected with 1  106 trophic forms or 1 
106 mixed P. murina organisms (Fig. 1A). The mixed P. murina
inoculum consisted of 9.01  105 trophic forms and 9.90  104
cysts. Neonates infected with trophic forms had higher trophic
burdens in the lungs at days 7 and 14 postinfection than mice
infected with mixed P. murina organisms (Fig. 1A). However, the
trophic lung burdens in the two groups were similar by day 21
postinfection (Fig. 1A and B). The cyst burden was below the limit
of detection of log10 3.12 organisms per lung during the first week
postinfection in BALB/cJ neonates infected with either trophic
forms or mixed P. murina organisms (Fig. 1C). Cysts were de-
tected at day 14 postinfection in both groups. Neonates infected
with trophic forms had higher cyst burdens in the lungs at day 14
postinfection than mice infected with mixedP.murina organisms,
but there was no statistically significant difference in the cyst bur-
den between the groups by day 21 postinfection (Fig. 1C). Neo-
nates infected with trophic forms and those infected with mixedP.
murina organisms displayed no differences in the clearance of
either trophic forms or cysts (Fig. 1B and D).
Cysts drive the early recruitment of activated T cells into the
alveolar spaces of neonatal mice. Based on previously published
reports, we predicted that the absence of cysts in the inoculum of
neonatal mice infected with trophic forms would yield a less ro-
bust response than infection with a normal mixture of trophic
forms and cysts (22). Clearance of Pneumocystis organisms re-
quires the generation of effective adaptive immune responses. We
have shown previously that adaptive responses are not observed in
immunocompetent neonatal mice until week 3 postinfection (9).
To determine if the absence of cysts in the inoculum affects the
neonatal adaptive immune response, T and B cells in the lungs of
neonates infected with trophic forms were compared with those of
FIG 1 Cysts are undetectable during the first week postinfection in BALB/cJ
neonates infected with P. murina trophic forms. Neonatal (24- to 72-h-old)
mice were infected i.n. with 106 trophic forms or mixed P. murina organisms.
Trophic (A and B) and cystic (C and D) burdens in the right lung lobes were
determined by enumeration of organisms on Diff-Quik-stained slides under a
microscope. Data are means  standard deviations for 3 to 4 mice per group
and are representative of 2 separate experiments. The limit of detection was
log10 3.12 nuclei per neonatal right lung lobe. Two-way ANOVA with a Holm-
Sidak post hoc test was used to compare mean trophic form or cyst numbers
between the groups. *, P 0.05.
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neonates infected with a normal mixture of P. murina organisms.
The numbers of activated CD44high CD62Llow CD4 and CD8 T
cells in the alveolar spaces (represented by cells collected in the
BALF) were significantly higher by week 3 postinfection in pups
infected with organisms that included cysts in the inoculum than
in pups infected with trophic forms only (Fig. 2A and C). No
differences were observed in the numbers of T cells in the lung
parenchyma (lung digest) (Fig. 2B and D). These data indicate
that the intensity of the early T cell response to P. murina in the
alveolar spaces is dependent on the presence of cysts in the inoc-
ulum. The numbers of CD19 B cells in the lungs did not differ
between pups infected with mixed P. murina organisms and those
infected with trophic forms (Fig. 2E). The numbers of activated T
cells and CD19 B cells in the alveolar spaces and lung paren-
chyma were equivalent for the two groups at days 28 and 40
postinfection.
To determine if the absence of cysts in the inoculum affects the
neonatal innate immune response, the expansion or recruitment
of alveolar or nonresident innate immune cells in neonatal mice
infected with trophic forms was compared with that in neonates
infected with a normal mixture of P. murina organisms. The level
of recruitment of CD11c CD11b nonresident innate immune
cells to the alveolar spaces (BALF) by week 3 postinfection was
higher in mice infected with mixed P. murina organisms than in
those infected with trophic forms alone, but these differences were
not statistically significant (Fig. 2G). The numbers of CD11c
CD11b innate immune cells increased by 3 weeks postinfection
in the alveolar spaces of neonates infected with either trophic
forms or mixed P. murina organisms (Fig. 2H). There were no
differences in these responses between the groups at days 28 and
40 postinfection (Fig. 2G and H).
P. murina trophic forms encyst by day 7 postinfection in
adult mice. Quantification of the fungal lung burden in neonatal
mice demonstrates that the cysts were below the limit of detection
during the first week after infection with either trophic forms or
mixed P. murina organisms. To determine if similar kinetics
would be observed in adults, we infected immunocompetent
BALB/cJ adult mice with trophic forms or mixedP.murina organ-
isms. Trophic forms were detected at day 5 postinfection in the
lungs of adults infected with trophic forms or mixed P. murina
organisms (Fig. 3A and C). Cysts were first detected at day 7
postinfection in the lungs of adults infected with trophic forms or
mixed P. murina organisms (Fig. 3B and D). The trophic and
cystic lung burdens were similar for the two groups at all time
points and peaked at day 14 postinfection (Fig. 3A to D). The
difference in the cyst burden at day 7 postinfection (Fig. 3B) was
not consistent in a repeat of the experiment (Fig. 3D). The trophic
and cystic lung burdens were below, or approaching, the limit of
FIG2 Cysts promote the recruitment of activated T cells in the BALF by day 21 postinfection in neonates. Neonatal (24- to 72-h-old) BALB/cJ mice were infected
i.n. with 106 trophic forms or mixed P. murina organisms. (A though F) Flow cytometry was used to phenotype activated CD44high CD62Llow CD4 T cells (A
and B), activated CD44high CD62Llow CD8 T cells (C and D), and CD19 B cells (E and F) in the BALF and lung digest. (G and H) Flow cytometry was used to
phenotype CD11c CD11b (G) and CD11c CD11b (H) nonlymphocytes with high granularity and size from the BALF. Data are means  standard
deviations for 3 to 4 mice per group and are representative of 2 separate experiments. For comparison of mean total cell numbers between the groups at individual
time points, t tests were used. *, P 0.05.
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detection of log10 3.42 organisms per lung by day 21 postinfection,
indicating that there were no differences in the clearance of P.
murina organisms between the groups (Fig. 3A to D).
Cysts drive the early recruitment of T and B cells into the
lungs of adult mice. To determine if cysts are required for the
early recruitment of T and B cells into the lungs of immunocom-
petent adult mice, we infected adult BALB/cJ mice with either
trophic forms or a normal mixture of P. murina organisms (Fig.
4). The robust early recruitment of activated CD44high CD62Llow
CD4 and CD8 T cells into the alveolar spaces (BALF) was de-
pendent on the presence of cysts in the inoculum (Fig. 4A and B).
Higher numbers of activated CD4 and CD8 T cells were also
observed at day 5 postinfection in the lung parenchyma of mice
infected with a mixture of trophic forms and cysts than in that of
mice infected with trophic forms alone (Fig. 4A and B). Cysts in
the inoculum also promoted the early recruitment of CD19 B
cells into the alveolar spaces and an early increase in the number of
CD19B cells in the TBLN (Fig. 4C). T and B cell numbers in mice
infected with trophic forms were similar to or greater than those in
mice infected with mixed P. murina organisms as the mice ap-
proached clearance at week 3 postinfection.
Cysts promote the early infiltration of nonresident innate
immune cells in adult mice. The level of recruitment of CD11c
CD11b nonresident innate immune cells to the alveolar spaces
(BALF) and lung parenchyma (lung digest) of adult BALB/cJ mice
by day 14 postinfection was higher in mice infected with cysts in
the inoculum than in those infected with trophic forms alone (Fig.
5A). The numbers of CD11c CD11b innate immune cells in-
creased during the first week postinfection in the alveolar spaces
and parenchyma of adults infected with mixed P. murina organ-
isms (Fig. 5B). The numbers of lung-resident CD11c CD11b
innate immune cells increased in the lung parenchyma of adults
infected with mixed P. murina organisms at day 5 postinfection,
but no statistically significant differences were observed in the
alveolar spaces between the two groups (Fig. 5C). Surface expres-
sion of the major histocompatibility complex (MHC) class II mol-
ecule I-Ad was higher on both CD11c CD11b and CD11c
CD11b innate immune cells in the alveolar spaces of mice in-
fected with mixed P. murina organisms than in those of mice
infected with trophic forms alone (Fig. 5D and E). These data
indicate that the presence of cysts in the initial inoculum shapes
the phenotype of the early innate immune response in adult mice.
Cysts drive the early production of IFN- in the alveolar
spaces of adultmice.Th1-, Th2-, and Th17-type responses have all
been associated with the clearance of P. murina organisms (25–
27). To determine if cysts promoted the early development of
Th1-type responses in the lungs, we evaluated cytokine produc-
tion following infection of BALB/cJ adult mice with either trophic
forms or a normal mixture of P. murina organisms. The early
production of IFN- in the BALF was higher in mice infected with
cysts in the inoculum than in those infected with trophic forms
alone (Fig. 6A). The level of IFN- production in the lungs of mice
infected with trophic forms remained lower at all time points than
that in mice infected with a mixture of P. murina organisms, de-
spite the presence of cysts by day 7 postinfection (Fig. 6A). In
addition, the proportion of CD4 T cells producing intracellular
IFN- at day 7 postinfection was higher in the lungs of mice in-
FIG 3 Cysts are undetectable before day 7 postinfection in BALB/cJ adults
infected with P. murina trophic forms. Adult mice were infected i.t. with 5 
106 trophic forms or mixed P.murina organisms. Trophic (A and C) and cystic
(B and D) lung burdens from two separate experiments were determined by
enumeration of organisms on Diff-Quik-stained slides under a microscope.
Data are means  standard deviations for 5 mice per group. The limit of
detection was log10 3.42 nuclei per adult right lung lobe. For comparison of
mean fungal burdens between the two groups at individual time points, t tests
were used. *, P 0.05.
FIG 4 Infection with the cyst life cycle stage drives the recruitment of T and B
cells into the lungs of adult mice. Adult BALB/cJ mice were infected i.t. with
5 106 trophic forms or mixedP.murina organisms. Flow cytometry was used
to phenotype activated CD4 T cells (A), activated CD8 T cells (B), and
CD19 B cells (C) in the BALF, lung digest, and TBLN. Activation of T cells
was evaluated by CD44 and CD62L expression. Data are means  standard
deviations for 5 mice per group and are representative of 2 separate experi-
ments. For comparison of mean total cell numbers between the groups at
individual time points, t tests were used. *, P  0.05; **, P  0.01; ***, P 
0.001.
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fected with mixed P. murina organisms than in those of mice
infected with trophic forms (Fig. 6B).
Trophic forms suppress -glucan-induced proinflamma-
tory cytokine production by dendritic cells. -Glucan from the
cell walls of Pneumocystis cysts has been shown previously to stim-
ulate the production of IL-1, IL-6, and TNF- in dendritic cells
and to induce IFN- production in cocultured T cells (21). To
evaluate whether trophic forms are able to stimulate proinflam-
matory cytokines, we measured IL-1, IL-6, and TNF- produc-
tion by bone marrow-derived dendritic cells (BMDCs) following
stimulation with trophic forms, a normal mixture of P. murina
organisms, and/or curdlan (Fig. 7). Curdlan is a high-molecular-
weight -1,3-glucan isolated from Alcaligenes faecalis and is ho-
mologous to the -1,3-glucan that makes up the P. murina cyst
wall (15). IL-1 and IL-6 production was stimulated by 5  105
mixed P. murina organisms and 10
g/ml curdlan, but not by 5
105 trophic forms (Fig. 7A and B). These data demonstrate that
cysts are required for the production of IL-1 and IL-6 by BM-
DCs. Stimulation of BMDCs with curdlan induced IL-1, IL-6,
and TNF- production (Fig. 7A to C). Conversely, our data indi-
cate that trophic forms suppress curdlan-induced IL-1, IL-6, and
TNF- production by BMDCs in a dose-dependent manner (Fig.
7A to C). Interestingly, 106 trophic forms suppressed the IL-6
production induced by 5 105 mixed P. murina organisms (Fig.
7B) but were insufficient to induce suppression of IL-1 produc-
tion (Fig. 7A). In contrast to IL-1 and IL-6 production, TNF-
production was stimulated by curdlan, but not by trophic forms
or mixed P. murina organisms (Fig. 7C). Moreover, incubation of
BMDCs with a high number of trophic forms or mixed P. murina
organisms suppressed curdlan-induced production of TNF-
(Fig. 7C). This reduction in the level of cytokine production was
not due to a toxic effect on the BMDCs (see Fig. S2 in the supple-
mental material).
The P. murina cell wall has been shown to contain more-com-
plex branching patterns, including -1,6-glucan, than those con-
tained in curdlan. The P. murina cell wall also includes mannosy-
lated proteins. To evaluate the ability of trophic forms to suppress
responses to a fungal cell wall, we measured cytokine production
following stimulation with trophic forms, zymosan, and/or de-
pleted zymosan (see Fig. S3 in the supplemental material). Zymo-
san is a protein-carbohydrate preparation from the cell wall of
Saccharomyces cerevisiae. Depleted zymosan is treated with hot
alkali to prevent engagement of the Toll-like receptors (TLRs).
Trophic forms suppressed the production of IL-1, IL-6, and
TNF- induced by zymosan or depleted zymosan.
To evaluate whether dendritic cells are able to present antigen
FIG 5 Cysts promote the early increase in CD11c CD11b innate immune cells and the infiltration of CD11c CD11b innate immune cells into the
alveolar spaces and lung parenchyma of adult mice. BALB/cJ adult mice were infected i.t. with 5 106 trophic forms or mixed P. murina organisms. (A to
C) Flow cytometry was used to phenotype CD11c CD11b (A), CD11c CD11b (B), and CD11c CD11b (C) nonlymphocytes with high granularity and
size from the BALF and lung digest. (D and E) Flow cytometry was used to compare the expression of the MHC class II molecule I-Ad on CD11c CD11b (D)
and CD11c CD11b (E) cells in the BALF. Data are means standard deviations for 5 mice per group and are representative of 2 separate experiments. For
comparison of mean total cell numbers between the groups at individual time points, t tests were used. *, P 0.05; **, P 0.01; ***, P 0.001.
FIG 6 Cysts stimulate production of the proinflammatory Th1-type cyto-
kine IFN- in the lungs of adult BALB/cJ mice. Adult mice were infected i.t.
with 5  106 trophic forms or mixed P. murina organisms. (A) IFN- cyto-
kine production in the supernatant of the first bronchoalveolar lavage was
quantified by ELISA. (B) Flow cytometry was used to evaluate intracellular
IFN- expression in CD4 cells in the lung digest at day 7 postinfection. Data
are means standard deviations for 5 mice per group and are representative of
2 separate experiments. For comparison of BALF IFN- levels between the
groups at individual time points (A) and for comparison of the percentages of
CD4 T cells expressing IFN- between the groups (B), t tests were used. **,
P 0.01.
Evans et al.
3200 iai.asm.org November 2016 Volume 84 Number 11Infection and Immunity
 o
n
 N
ovem
ber 27, 2017 by guest
http://iai.asm
.org/
D
ow
nloaded from
 
and induce Th1-type responses when loaded with trophic forms,
we stimulated BMDCs cocultured with CD4 T cells with either
mixedP.murina organisms or trophic forms. BMDCs loaded with
mixed P. murina organisms, but not with trophic forms, stimu-
lated IFN- production in CD4 T cells (Fig. 8). The addition of
curdlan did not improve IFN- production in response to trophic
forms (data not shown). These data demonstrate that cysts are
required for effective Th1-type responses in vitro and are consis-
tent with our findings in vivo that cysts drive the early T cell re-
sponse to P. murina.
Trophic forms suppress TLR2- and TLR4-induced proin-
flammatory cytokine production by dendritic cells. In addition
to C-type lectin receptors such as dectin-1, Pneumocystis species
have been shown to stimulate cytokine production by antigen-
presenting cells via TLR2 and TLR4 (28, 29). We measured IL-1,
IL-6, and TNF- production by BMDCs following stimulation
with TLR2-agonist LTA, TLR4-agonist LPS, and/or trophic forms
(Fig. 9). Stimulation of BMDCs with LTA or LPS induced IL-1,
IL-6, and TNF- production (Fig. 9A to F). The addition of 5 
105 trophic forms suppressed this cytokine response to LTA
and LPS.
The suppression of the response to curdlan is not mediated
by mannose receptor. Carbohydrate PAMPs on the surfaces of
fungi and other microorganisms may be recognized by C-type
lectin receptors. Mannose receptor and dectin-1 have been im-
plicated in the immune response to Pneumocystis species (30–
35). To evaluate the role of mannose receptor and dectin-1 in the
response to trophic forms and -glucan, we stimulated BMDCs
deficient in those C-type lectin receptors with trophic forms,
mixed P. murina organisms, and/or curdlan (Fig. 10). Surpris-
ingly, neither mannose receptor nor dectin-1 was required for
IL-6 or TNF- production in response to mixed P. murina organ-
isms. IL-1 production in response to mixed P. murina organisms
FIG7 Cysts, but not trophic forms, stimulate production of the proinflammatory cytokines IL-1 and IL-6 by BMDCs in vitro. BMDCs from adult BALB/cJ mice
were incubated with 5 105 trophic forms or 5 105 mixed P. murina organisms for 72 h. Curdlan was included as a positive control for cytokine production.
IL-1 (A), IL-6 (B), and TNF- (C) cytokine production was quantified by ELISA. Data are means standard deviations for 3 biological replicates per group and
are representative of at least 2 separate experiments. One-way ANOVA with a Student-Newman-Keuls post hoc test was used to compare supernatant cytokine
concentrations between the groups. *, P 0.05; **, P 0.01; ***, P 0.001; n.s., not statistically significant.
FIG 8 Cysts, but not trophic forms, stimulate production of the proinflam-
matory Th1-type cytokine IFN- by CD4
 T cells in vitro. CD4 T cells and
BMDCs from adult BALB/cJ mice were incubated with trophic forms or mixed
P. murina organisms for 72 h. IFN- cytokine production was quantified by
ELISA. Data are means  standard deviations for 3 biological replicates per
group and are representative of 3 separate experiments. One-way ANOVA
with a Student-Newman-Keuls post hoc test was used to compare supernatant
IFN- concentrations between the groups. **, P  0.01; n.s., not statistically
significant.
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was modestly dependent on dectin-1. As expected, mannose re-
ceptor was not responsible for the response to curdlan. Depletion
of dectin-1 did not fully abolish the IL-6 and TNF- responses to
curdlan. It is possible that other receptors, such as complement
receptor 3, may recognize this -1,3-glucan or that the curdlan
preparation contained additional PAMPs beyond -1,3-glucan.
Neither mannose receptor nor dectin-1 was exclusively required
for the trophic-form-mediated suppression of IL-1, IL-6, and
TNF- production. In the absence of mannose receptor or dec-
tin-1, there was a modest increase in IL-6 production by BMDCs
treated with curdlan and trophic forms over that by wild-type
BMDCs. Together, these data demonstrate that dectin-1 does not
contribute significantly to the IL-1, IL-6, or TNF- response to
mixed P. murina organisms but is involved in signaling -glucan
responses, though not exclusively. Furthermore, mannose recep-
tor has only a minor role in the inhibitory effects of trophic forms
on -glucan stimulation of IL-6 production. These data suggest
that other pattern recognition receptors are involved in signaling
in both the proinflammatory and the suppressive functions of P.
murina life forms.
FIG 9 Trophic forms suppress LTA- and LPS-mediated cytokine production. BMDCs from adult BALB/cJ mice were incubated with 5 105 trophic forms, 10

g/ml LTA (A to C), and/or 100 ng/ml LPS (D to F) for 72 h. IL-1 (A and D), IL-6 (B and E), and TNF- (C and F) cytokine production was quantified by ELISA.
Data are means  standard deviations for 3 biological replicates per group and are representative of 3 separate experiments. One-way ANOVA with a
Student-Newman-Keuls post hoc test was used to compare supernatant cytokine concentrations among the groups when the data were parametric (D and E) (***,
P 0.001). Kruskal-Wallis one-way ANOVA on ranks was used to compare differences among the groups when the data were nonparametric (A, B, C, and F)
(*, P 0.05).
FIG 10 The response to trophic forms and cysts is not exclusively dependent on the C-type lectin receptors dectin-1 and mannose receptor. BMDCs from
wild-type C57BL/6 littermate control, MR/, and dectin-1 KO adult mice were incubated with 5 105 trophic forms or 5 105 mixed P. murina organisms
for 72 h. Curdlan was included as a positive control for cytokine production. IL-1 (A), IL-6 (B), and TNF- (C) cytokine production was quantified by ELISA.
Data are means standard deviations for 3 biological replicates per group and are representative of 3 separate experiments. Kruskal-Wallis one-way ANOVA on
ranks was used to compare differences among the groups when the data were nonparametric. *, P 0.05.
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DISCUSSION
Our data confirm that cysts drive immune responses to infection
with P. murina. Cysts promote the early recruitment of activated
CD4 and CD8T cells into the lungs of neonatal and adult mice.
Cysts also promote the early recruitment of nonresident innate
immune cells and CD19 cells into the alveolar spaces of adult
mice. Cysts in the inoculum stimulate the production of IFN-.
Importantly, we found for the first time that trophic forms sup-
press -glucan-, LTA-, and LPS-induced proinflammatory cyto-
kine production by dendritic cells. Furthermore, dendritic cells
cultured with trophic forms failed to stimulate the production of
IFN- by CD4 T cells. Our data are consistent with the cyst life
cycle stage driving proinflammatory responses that direct the early
recruitment of innate and adaptive immune cells. However, the
trophic life cycle forms dampen -glucan- and TLR-induced in-
flammation. This is a novel finding and suggests that the two life
forms of Pneumocystis balance the immune response to the organ-
isms.
We have reported previously that there is a delay in the im-
mune response to P. murina in neonatal mice relative to that in
adults (9–12). Despite the delay, the immune response is sufficient
to mediate the clearance of P. murina organisms. This delayed
response represents a balance between clearance of a pathogen
and avoidance of inflammatory damage during postpartum devel-
opment. Here we report that cysts in the inoculum drive adaptive
immune responses to P. murina in neonatal mice by day 21
postinfection. The fungal burdens in neonates infected with
trophic forms or mixed P. murina organisms were similar by day
21 postinfection. These data suggest that the composition of the
inoculum shapes the immune responses that will eventually de-
velop.
Redundant Th1-, Th2-, and Th17-type responses are associated
with the clearance of Pneumocystis organisms (1, 3, 4, 25–27).
Here we report that cysts are required in the inoculum to stimulate
the production of intracellular IFN- by CD4 T cells in adult
mice at day 7 postinfection. CD8 T cells are not required for the
clearance of Pneumocystis organisms but contribute to the pro-
duction of proinflammatory cytokines, including IFN-, that me-
diate effector responses (36). The concentration of extracellular
IFN- in the alveolar spaces of adult mice infected with trophic
forms did not change over the course of infection, despite eventual
increases in the cyst burden and the numbers of activated CD4
and CD8 T cells. This may suggest that trophic forms suppress
Th1-type responses, which would be consistent with our in vitro
data.
Mice infected with trophic forms developed detectable cysts by
day 7 (in adults) or day 14 (in neonates) postinfection. We were
unable to discern in our models whether trophic forms are capable
of inducing protective immune responses or whether the response
to trophic forms is merely delayed. The reduced ability of trophic
forms to stimulate IFN- expression does not preclude the gener-
ation of protective responses, since there is redundancy in the
types of T helper responses that can mediate the clearance ofPneu-
mocystis organisms (25–27). It has been reported previously (22),
and our preliminary data using an echinocandin to prevent the
formation of cysts suggest, that infection with trophic forms is
sufficient to generate protective CD4 T cell and antibody re-
sponses (data not shown).
Clearance of Pneumocystis organisms is also dependent on al-
veolar macrophage responses (2). Our data demonstrate that cysts
drive increases in the numbers of CD11c CD11b lung-resident
innate immune cells. This population includes activated alveolar
macrophages (9). We found that cysts promote MHC class II ex-
pression on the surfaces of immune cells in the alveolar spaces.
Decreased antigen presentation in the absence of cysts may have
contributed to the less-robust T cell response observed in mice
infected with trophic forms. Additionally, cysts drive the early
infiltration of CD11c CD11b innate immune cells into the
lungs. This population consists of monocytes, small macrophages,
and neutrophils. Neutrophils are not required for clearance, but
their accumulation in the lungs correlates with disease severity in
human Pneumocystis pneumonia patients (5, 37).
Infection with trophic forms in the absence of cysts leads to the
establishment of an immunosuppressive environment in the
lungs that persists for as long as 1 week following the formation of
the cystic stage. If cysts are in the inoculum, the trophic form is
unable to suppress inflammatory responses in the lungs as defin-
itively. We predict that infection with pure cysts, in the absence of
trophic forms, would lead to accelerated inflammatory responses
compared to those induced by infection with a mixture of organ-
isms. Unfortunately, there is no reliable method for isolating P.
murina cysts in appreciable quantities.
Other groups report difficulties in stimulating IL-1, IL-6, and
TNF- cytokine production by antigen-presenting cells using un-
opsonized mixed P.murina organisms (34). We found that a mul-
tiplicity of infection of 50 mixed P. murina organisms to 1 BMDC
was sufficient to induce IL-1 and IL-6 production. We attribute
the necessity of this relatively high multiplicity of infection to the
presence of trophic forms in the mixture, since our data demon-
strate that trophic forms suppressed the production of the -glu-
can-induced proinflammatory cytokines IL-1, IL-6, and TNF-
by BMDCs. A multiplicity of infection of 50 P. murina organisms
per dendritic cell is composed of approximately 5 cysts capable of
stimulating positive cytokine responses plus 45 trophic forms,
which will act to suppress these responses. Preliminary gene ex-
pression data demonstrate that BMDCs stimulated with curdlan
or mixed P. murina organisms, but not with trophic forms, ex-
press IL-1, IL-6, and TNF- mRNAs (data not shown). This
suggests that the trophic forms suppress cytokine production
rather than cytokine secretion.
Interestingly, mixed P. murina organisms also failed to induce
TNF- in BMDCs in our model. TNF- production is associated
with protection against P. murina, and has been reported in
BMDCs following stimulation with -glucan extracted from the
cell wall of the cyst life cycle stage (21). We propose that trophic
forms, which make up approximately 90% of the organisms in
mixed P. murina infection, are sufficient to suppress the produc-
tion of TNF- by BMDCs, which would otherwise be induced by
-glucan on the surfaces of the cysts. In agreement with this con-
tention, we found that trophic forms inhibited cytokine produc-
tion by curdlan-stimulated BMDCs.
C-type lectin receptors are transmembrane proteins that bind
carbohydrates (38). Activation triggers phagocytosis, as well as
signaling cascades that culminate in the activation of antigen-pre-
senting cells and the production of inflammatory cytokines. Den-
dritic cells have been shown to respond to Pneumocystis cyst wall
-glucans via dectin-1 (21). Dectin-1 is required for the genera-
tion of an effective response to Pneumocystis infection (35). Pre-
vious work has shown that mannose receptor binds glycoprotein
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A on the surfaces of Pneumocystis cells, triggering phagocytosis,
reactive oxygen species production, and NF-B-mediated pro-
duction of IL-8 (31–33). Here we demonstrate that neither dec-
tin-1 nor mannose receptor was exclusively required for the pro-
duction of IL-1, IL-6, and TNF- by BMDCs in response to P.
murina. Our data suggest redundancy in the receptors that recog-
nize cysts and trophic forms.
Conversely, some C-type lectin receptors may suppress proin-
flammatory responses. Engagement of the C-type lectin receptor
mincle by the fungal skin pathogen Fonsecaeamonophora has been
shown to suppress proinflammatory responses induced by dectin-
1-mediated signaling (39). Zhang et al. demonstrated that block-
age or knockdown of mannose receptor on rat alveolar macro-
phages resulted in elevated TNF- production in response to
unopsonized mixed Pneumocystis organisms (34). Here we dem-
onstrate that the deletion of mannose receptor on dendritic cells
resulted in a modest decrease in the ability of trophic forms to
suppress the production of IL-6 in response to -glucan, indicat-
ing that suppression is mediated through mechanisms other than
mannose receptor. We are currently examining whether mincle
could mediate the suppressive activity of trophic forms, as was
found for F. monophora.
Our data indicate that trophic forms suppress cytokine re-
sponses to the TLR2 agonist LTA and the TLR4 agonist LPS. In
one paper, mice with mutant TLR4 were shown to have reduced
IL-10, IL-12p40, and MIP-2 levels in the BALF of Pneumocystis-
infected mice and enhanced levels of TNF and IL-6, with no dif-
ference in the clearance of the organisms (28). In addition, dec-
tin-1 acts synergistically with TLR2 and TLR4 to promote
cytokine production following stimulation with curdlan (40). Si-
multaneous inhibition of dectin-1-, TLR2-, and TLR4-mediated
signals may permit the trophic forms to broadly dampen the pro-
inflammatory response and protect the colonization of the immu-
nocompetent host by Pneumocystis organisms. The suppression of
zymosan- and depleted-zymosan-stimulated cytokine production
provides further evidence that trophic forms broadly dampen the
response to carbohydrate and protein agonists.
The inflammatory potential of the cysts in the face of a 10-fold
excess of suppressive trophic forms should not be understated.
The ability of trophic forms to suppress cytokine production is
dose dependent, and our data suggest that slight changes in the
ratio of trophic forms to cysts may shift the balance between sup-
pression and stimulation. Increasing the trophic form-to-cyst ra-
tio from 10:1 to 12:1 (by the addition of 105 trophic forms) is
sufficient for the trophic forms to begin to reduce the IL-6 re-
sponse to the mixed population. Our in vivo data indicate that the
cyst burden remains low during the first week postinfection but
that cysts in the inoculum drive the initial inflammation. The
rapid establishment of an immunosuppressive trophic population
may be critical for avoiding preemptive detection and clearance by
immunocompetent hosts. Conversely, immunocompromised
mice with severe pneumonia experience a final burst of trophic
growth, in which the ratio of trophic forms to cysts reaches a level
as high as 30:1 (unpublished observation). This population shift
may prolong the life of the immunocompromised host by damp-
ening inflammation and may extend the window of opportunity
for the transmission of cysts to additional hosts.
The inoculation with trophic forms employed in this study
does not mimic the natural route of infection, since cysts are the
transmittable life cycle stage of Pneumocystis species (24). In ac-
cordance with our goal, our approach allows conclusions to be
formed about the differential immune responses to the life cycle
stages of Pneumocystis species. Recently, it was reported that treat-
ment of immune-reconstituted mice with the-1,3-D-glucan syn-
thase inhibitor anidulafungin results in depletion of cysts, with the
remaining trophic burden stimulating a much-reduced inflam-
matory response (22). Anidulafungin belongs to a drug class
known as the echinocandins, which have been used in combina-
tion with other antifungals in the treatment ofPneumocystis pneu-
monia in human patients (41). Linke et al. propose that depletion
of cysts would reduce inflammation-induced lung damage in pa-
tients (22). Our data corroborate this suggestion and highlight the
need for greater understanding of the response to the trophic
stage. We propose that depletion of the immunostimulatory cysts
in the presence of the immunosuppressive trophic forms may
hamper the ability of immunocompromised patients or infants to
control the infection. However, the net outcome may be positive,
since lung damage during Pneumocystis pneumonia is predomi-
nately due to the inflammatory immune response.
In summary, our data indicate that cysts are the primary form
of Pneumocystis responsible for provoking adult and neonatal im-
mune responses to infection with P. murina. These responses in-
clude infiltration of nonresident innate immune cells and the re-
cruitment of CD19B cells and activated CD4 and CD8T cells.
Cysts are required to stimulate the production of IFN- by CD4
T cells in vitro and in the alveolar spaces of immunocompetent
adult mice. We found that trophic forms suppress -glucan-in-
duced proinflammatory cytokine production by dendritic cells.
We propose that the suppression of immune responses by the
trophic forms promotes the colonization of immunocompetent
hosts by Pneumocystis and may be beneficial to immunocompro-
mised hosts by dampening the inflammatory responses that con-
tribute to lung pathology during PcP. This differential immune
response to Pneumocystis trophic forms and cysts is most certainly
a leading contributor to the success of the organisms as human
pathogens.
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